Amjevita

Generic name: adalimumab-atto

Used for: Rheumatoid arthritis and juvenile arthritis (JIA) · Psoriatic arthritis · Ankylosing spondylitis (arthritis of the spine) · Crohn’s disease · Ulcerative colitis · Plaque psoriasis · Hidradenitis suppurativa (painful lumps under the skin) · Non-infectious uveitis (inflammation in the middle or back of the eye) · 7 more

How do you pay?

How to pay the least

Ask for the cash price

Amjevita

Amjevita is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold.

  1. Ask your pharmacy for Amjevita’s cash price, and one or two other pharmacies too.
  2. Amjevita’s savings card works only with insurance from a job or one you bought.

Compare every option

Question
Brand nameAmjevita
Authorized genericadalimumab-atto
Regular genericadalimumab-atto
What you’d pay
Cash priceAsk the pharmacy
Not soldThere isn’t one
Not soldAsk the pharmacy
Same as Amjevita?
The original
–
–

Brand nameThe maker’s card

AMJEVITA Co-Pay Card (Amgen SupportPlus)

Savings card from Amgen

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $0 a dose

Sign up on amjevita.com 

Or call 1-833-442-6436.

In the maker’s words

“Pay as little as $0 out-of-pocket for each dose…”

From the maker’s offer on amjevita.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Brand nameTrumpRx.gov price

TrumpRx.gov, the federal government’s drug price site, lists Amjevita at a price its maker agreed to, for people paying without insurance.

  • TrumpRx.gov $299Autoinjector, 40/0.4 mg/mLGet the free coupon on TrumpRx’s page and show it at the pharmacy.

From TrumpRx.gov, read October 28, 2026. Its page opens on this price; other strengths and amounts are priced there too. With insurance, check your co-pay first: it may be lower.

Authorized genericNot sold

There isn’t one. An authorized generic is Amjevita itself, from the same company, sold without the brand name, and usually for less. For now Amjevita is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

Amjevita is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

AMJEVITA is a tumor necrosis factor (TNF) blocker indicated for:

  • Reducing signs and symptoms, inducing major clinical response, inhibiting the progression of structural damage, and improving physical function in adult patients with moderately to severely active rheumatoid arthritis.
  • Reducing signs and symptoms of moderately to severely active polyarticular juvenile idiopathic arthritis in patients 2 years of age and older.
  • Reducing signs and symptoms, inhibiting the progression of structural damage, and improving physical function in adult patients with active psoriatic arthritis.
  • Reducing signs and symptoms in adult patients with active ankylosing spondylitis.
  • Treatment of moderately to severely active Crohn's disease in adults and pediatric patients 6 years of age and older.
  • Treatment of moderately to severely active ulcerative colitis in adult patients. Limitations of Use: Effectiveness has not been established in patients who have lost response to or were intolerant to TNF blockers.
  • Treatment of adult patients with moderate to severe chronic plaque psoriasis who are candidates for systemic therapy or phototherapy, and when other systemic therapies are medically less appropriate.
  • Treatment of moderate to severe hidradenitis suppurativa in patients 12 years of age and older.
  • Treatment of non-infectious intermediate, posterior, and panuveitis in adults and pediatric patients 2 years of age and older.

Source: the FDA label for Amjevita (Amgen USA Inc.), July 13, 2026. Full label on DailyMed 

Good to know

Prices checked November 2, 2026. Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/amjevita/